NCT00283621: Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide |
|
|
| Completed | N/A | 51 | US | Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), Adriamycin, Doxorubicin Hydrocholoride, Adriamycin PFS, Adriamycin RDF, Ifosfamide, Ifex | M.D. Anderson Cancer Center, Amgen | Sarcoma | 04/06 | 04/06 | | |
